BNP Paribas Financial Markets’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $110K | Buy |
13,034
+3,191
| +32% | +$27K | ﹤0.01% | 3176 |
|
|
2025
Q1 | $79.1K | Sell |
9,843
-8,232
| -46% | -$66.2K | ﹤0.01% | 3295 |
|
|
2024
Q4 | $162K | Sell |
18,075
-14,003
| -44% | -$126K | ﹤0.01% | 3134 |
|
|
2024
Q3 | $235K | Buy |
32,078
+20,324
| +173% | +$149K | ﹤0.01% | 2482 |
|
|
2024
Q2 | $67.1K | Sell |
11,754
-66,712
| -85% | -$381K | ﹤0.01% | 2711 |
|
|
2024
Q1 | $393K | Buy |
78,466
+8,398
| +12% | +$42.1K | ﹤0.01% | 2331 |
|
|
2023
Q4 | $630K | Sell |
70,068
-19,492
| -22% | -$175K | ﹤0.01% | 1998 |
|
|
2023
Q3 | $696K | Buy |
89,560
+54,477
| +155% | +$423K | ﹤0.01% | 1910 |
|
|
2023
Q2 | $340K | Sell |
35,083
-20,759
| -37% | -$201K | ﹤0.01% | 2183 |
|
|
2023
Q1 | $612K | Buy |
55,842
+22,976
| +70% | +$252K | ﹤0.01% | 2025 |
|
|
2022
Q4 | $142K | Sell |
32,866
-31,535
| -49% | -$136K | ﹤0.01% | 2475 |
|
|
2022
Q3 | $484K | Buy |
64,401
+34,078
| +112% | +$256K | ﹤0.01% | 2341 |
|
|
2022
Q2 | $305K | Sell |
30,323
-26,008
| -46% | -$261K | ﹤0.01% | 2292 |
|
|
2022
Q1 | $697K | Buy |
56,331
+56,228
| +54,590% | +$696K | ﹤0.01% | 2031 |
|
|
2021
Q4 | $2.36K | Sell |
103
-1,690
| -94% | -$38.7K | ﹤0.01% | 3333 |
|
|
2021
Q3 | $39.7K | Buy |
+1,793
| New | +$39.7K | ﹤0.01% | 2970 |
|